Promoter hypermethylation of p16 gene and DAPK gene in sera from hepatocellular carcinoma (HCC) patients

Chinese Journal of Cancer Research

Volumn 17, Issue 4, 2005, Pages 250-254

  Lin, Qing ^a   Chen, Long Bang ^a   Tang, Yong Ming ^b   Wang, Jing ^b  

^a NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

^b No 454 Hospital of PLA   (China)

Author keywords

DAPK gene; DNA methylation; HCC; p16 gene; Serum

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; DNA; PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CPG ISLAND; DISEASE COURSE; DNA METHYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

EID: 30444452833     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-005-0020-7     Document Type: Article

References (14)

1. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma[J]. Gastroenterol Hepatol 1997; 12: S294-S308.
2. Ng EKO, Tsui NBY, Lam NYL, et al. Presence of filterable and nonfilterable mRNA in the mRNA in the plasma of cancer patients and healthy individuals[J]. Clin Chem 2002; 48: 1212-7.
3. Qiu W, Zhou B, Zou H, et al. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma[J]. Am J Pathol 2004; 165: 1689-99.
4. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands[J]. Natl Acad Sci USA 1996; 93: 9821-6.
5. Gonzalez-Gomez P, Bello MJ, Lomas J, et al. aberrant methylation of multiple genes in neuroblastic tumors: relationship with MYCN amplification and allelic status at 1p[J]. Europ J Cancer 2003; 39: 1478-85.
6. Hsu HS, Wang YC, Tseng RC, et al. 5′ cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer[J]. Clin Cancer Res 2004; 10: 4734-41.
7. Yu J, Zhang H, Gu J, et al. Methylation profiles of thirty four promoter-CpG island and concordant methylation behaviors of sixteen genes that may contribute to carcinogenesis of astrocytoma[J]. BMC Cancer 2004; 4: 65.
8. Yu J, Ni M, Xu J, et al. Methylation profiling of twenty promoter-CpG island of genes which may contribute to hepatocellular carcinogenesis[J]. BMC Cancer 2002; 2: 29.
9. Anker P, Stroun M. Progress in the knowledge of circulating nucleic acids: plasma RNA is particle associated. Can it become a general detection marker for a cancer blood test[J]? Clin Chem 2002; 49: 1210-1.
10. Alonso ME, Bello MJ, Gonzalez-Gomez P, et al. Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas[J]. Cancer Genet Cytogenet 2003; 144: 134-42.
11. Ivy HN, Wong YM, Dennis Lo, et al. Relationship of p16 methylation status and serum α-fetoprotein concentration in hepatocellular carcinoma patients[J]. Clin Chem 2000; 46: 1420-2.
12. Pellise M, Castells A, Gines A, et al. Detection of lymph node micrometastases by gene promoter hypermethylation in samples obtained by endosonography-guided fine-needle aspiration biopsy[J]. Clin Cancer Res 2004; 10: 4444-9.
13. Schagdarsurengin U, Wilkens L, Steinemann D, et al. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma[J]. Oncogene 2003; 22: 1866-71.
14. Guan XX, Chen LB. A prospect for early diagnosis of non-small cell lung cancer patients by detection of plasma DNA[J]. Oncol Prog 2003; 1: 187-90.